
A common artificial sweetener could make cancer treatments less effective, a new study has found.Sucralose, a sweetener found in many diet sodas, low-calorie snacks and powdered sugar substitutes, could interfere with immunotherapy in cancer patients, according to research from the University of Pittsburgh and UPMC Hillman Cancer Center.The study included 132 patients with melanoma (a deadly form of skin cancer) and nonsmall cell lung cancer (the most common type of lung cancer).YOUR DAILY DIET SODA COULD BE AGING YOUR BRAIN FASTER THAN YOU THINK, STUDY FINDSAll patients were taking anti-PD1 (a type of immunotherapy), either alone or in combination with chemotherapy. They all completed dietary questionnaires that indicated the volume of artificial sweeteners they consumed.The researchers found that the patients who consumed high levels of sucralose had a "worse response" to immunotherapy and "poorer survival" than those who consumed low amounts, according to a press release."We found that sucralose impeded the… ...[TheTopNews] Read More.
1 week ago